# Batch Risk of Bias Eval Report

This report contains an audit trace: explicit extracted evidence, model-provided rationales, and label comparisons. It does not include hidden chain-of-thought.

- Studies: 5
- Domains: 25
- Accuracy: 13/25 (52.0%)

## Summary

| PMID | Study | Correct | Accuracy | Seconds |
|---|---|---:|---:|---:|
| 19487623 | King 2009 | 3/5 | 60.0% | 117.59 |
| 20579848 | Palacios 2009 | 2/5 | 40.0% | 49.27 |
| 21775755 | Ziegler 2011 | 3/5 | 60.0% | 72.84 |
| 22928960 | Houry 2012 | 2/5 | 40.0% | 70.52 |
| 23148458 | Sheridan 2012 | 3/5 | 60.0% | 49.18 |

## Error Types

- under-called_due_to_missing_or_underused_evidence: 6
- over-inferred_from_sparse_reporting: 4
- blinding_outcome_type_or_role_confusion: 2

## 19487623 - King 2009

- Mode: hybrid
- Review context: none (0 chars)
- Article chars: 24566
- Extraction context chars: 12006
- Total seconds: 117.59

### Methodology Extraction

- `randomization_method`: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years).
- `allocation_concealment_method`: Not reported
- `blinding_participants`: Not reported
- `blinding_personnel`: Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated.
- `blinding_outcome_assessors`: The evaluating clinician monitored efficacy and was blinded to adverse events. Evaluating clinicians from all sites were trained to reliability on the CYBOCS-PDD, CGI-I, and Clinical Global Impressions, Severity of Illness Scale at the beginning and midpoint of the trial.
- `attrition_details`: 149 were randomized to receive citalopram (n=73) or placebo (n=76). Most participants (82.6%) completed the 12-week trial. In the citalopram-treated group, 12.3% stopped early due to adverse events and another 2.7% withdrew consent; in the placebo group, 9.2% left early owing to adverse events and another 6.6% withdrew consent. For subjects who failed to complete all postrandomization assessments, the last observation was carried forward.
- `study_design`: Randomized, placebo-controlled, parallel-group trial (RCT).
- `additional_notes`: Placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications. Liquid citalopram (Celexa, 10 mg/5 mL) was obtained commercially. All efficacy and safety analyses used the intent-to-treat principle.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |
| Allocation concealment | Unclear risk | Unclear risk | yes |  |
| Blinding of participants and personnel: All outcomes | Low risk | Low risk | yes |  |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk | yes |  |
| Incomplete outcome data: All outcomes | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: The study explicitly reports use of permuted block randomization with randomly varying block sizes, which is a valid random method per Cochrane criteria, so risk of bias from sequence generation is low.
- Model support: Quote: "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years)." Comment: Probably done — a random component (permuted blocks with randomly varying block sizes) is explicitly described, indicating adequate random sequence generation.
- Model support context: [{"source": "article", "quote": "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years).", "relevance": "Explicit description of a random sequence generation method (permuted blocks with random block sizes)."}, {"source": "methodology", "quote": "randomization_method: \"Participants were randomly assigned ... using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years).\"", "relevance": "Extracted methodological info corroborating the article's statement about random sequence generation."}]
- GT support: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years)
- Evidence row: {}
- Source context preview: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years). Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated. --- ## Methods --- ## Randomization and Blinding --- The primary analysis compared the proportion of subjects showing a positive response between groups using the χ2 test. For subjects who failed to complete...

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Unclear risk
- Match: True
- Model rationale: The report details the randomization scheme but provides no information on central allocation, sealed envelopes, or pharmacy-controlled procedures to prevent foreknowledge. Without explicit information on safeguards preventing foreseeing assignments, risk of selection bias cannot be determined.
- Model support: Quote: "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years)." Comment: Allocation sequence generation is described, but allocation concealment method is not reported in the text. Probably not done or not reported — insufficient information to judge whether recruiters/enrollers could foresee assignments.
- Model support context: [{"source": "article", "quote": "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years).", "relevance": "Describes random sequence generation but gives no information on concealment mechanisms."}, {"source": "methodology", "quote": "allocation_concealment_method: Not reported", "relevance": "Explicitly indicates concealment method was not described in extracted methods."}]
- GT support: Details not provided
- Evidence row: {}
- Source context preview: ## Methods --- Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years). Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated. --- Two hundred forty-four of 331 participants screened by telephone were presumed eligible and were invited for a screening visit. Consent was obtained for 175 subjects, and 149 were randomized...

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: Both participants and treating/evaluating clinicians were masked and placebo was matched to active drug, making it unlikely that knowledge of allocation influenced outcomes; thus performance bias is unlikely.
- Model support: Quote: "Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated." Comment: Participants received placebo matched for smell, taste, and viscosity; clinicians were masked and procedures preserved blinding of participants and key personnel. Probably done—blinding appears adequate and unlikely to have been broken.
- Model support context: [{"source": "article", "quote": "Two masked clinicians met with participants during each scheduled evaluation.", "relevance": "Shows clinician masking at participant evaluations, key for performance bias."}, {"source": "methodology", "quote": "Placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications.", "relevance": "Indicates credible placebo likely maintained participant blinding."}]
- GT support: Two masked clinicians met with participants during each scheduled evaluation
- Evidence row: {}
- Source context preview: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years). Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated. --- Two hundred forty-four of 331 participants screened by telephone were presumed eligible and were invited for a screening visit. Consent was obtained for 175 subjects, and 149 were randomized to receive...

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The primary and key secondary outcomes were clinician-rated and assessed by evaluators who were explicitly masked and trained to reliability, reducing the likelihood that knowledge of allocation influenced outcome assessment.
- Model support: Quote: "Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. Evaluating clinicians from all sites were trained to reliability on the CYBOCS-PDD, CGI-I, and Clinical Global Impressions, Severity of Illness Scale at the beginning and midpoint of the trial." Comment: Probably done — outcome assessment (CGI-I, CYBOCS-PDD and other clinician-rated scales) was performed by masked/evaluating clinicians with reliability training, making it unlikely that knowledge of allocation biased outcome measurement.
- Model support context: [{"source": "article", "quote": "Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events.", "relevance": "Shows outcome assessors were masked to treatment and distinct from treating clinician."}, {"source": "article", "quote": "Evaluating clinicians from all sites were trained to reliability on the CYBOCS-PDD, CGI-I, and Clinical Global Impressions... at the beginning and midpoint of the trial.", "relevance": "Demonstrates standardized, reliable blinded assessment of primary and key secondary outcomes."}]
- GT support: The evaluating clinician monitored efficacy and was blinded to AEs
- Evidence row: {}
- Source context preview: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years). Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events. The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated. --- The primary outcome measure was the CGI-I rated by the evaluating clinician. The CGI-I is a subscale scored from 1 (very much improved) to 7 (very much worse).23 A score of 4 reflects no change. Positive...

#### Incomplete outcome data: All outcomes

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: Attrition was moderate (~17%) and similar across arms with comparable reasons; missing data were handled by ITT with LOCF. Given balance and modest amount, missingness is unlikely related to true outcome enough to cause material bias.
- Model support: Quote: "Most participants (82.6%) completed the 12-week trial. In the citalopram-treated group, 12.3% stopped early due to adverse events and another 2.7% withdrew consent; in the placebo group, 9.2% left early owing to adverse events and another 6.6% withdrew consent. For subjects who failed to complete all postrandomization assessments, the last observation was carried forward." Comment: Missing data were modest (≈17.4% overall), balanced across groups with similar reasons, and ITT analysis with LOCF was used. The amount and pattern of missingness are unlikely to bias results materially. Probably done: reasonable handling and balance of attrition.
- Model support context: [{"source": "article", "quote": "Most participants (82.6%) completed the 12-week trial... 12.3% stopped early due to adverse events... placebo group, 9.2% left early... another 6.6% withdrew consent.", "relevance": "Shows proportion and reasons for attrition and balance between groups."}, {"source": "methodology", "quote": "For subjects who failed to complete all postrandomization assessments, the last observation was carried forward.", "relevance": "Describes how missing data were handled in the primary analyses."}]
- GT support: LTFU citalopram: 13 withdrew, 1 due to serious AE; 8 AEs; 2 protocol violations; 2 consent withdrawn LTFU placebo: 13 withdrawn, 7 AEs; 1 protocol violation; 5 consent withdrawn
- Evidence row: {}
- Source context preview: The primary analysis compared the proportion of subjects showing a positive response between groups using the χ2 test. For subjects who failed to complete all postrandomization assessments, the last observation was carried forward. For comparison purposes, analyses were also performed among subjects who completed all assessments. A similar approach was followed for each secondary outcome. All analyses are performed using commercially available software (SAS version 9.1; SAS Institute, Cary, North Carolina). Unless otherwise specified, all statistical tests were performed at a 5% level of significance (2-sided). --- Two hundred forty-four of 331 participants screened by telephone were...


## 20579848 - Palacios 2009

- Mode: hybrid
- Review context: none (0 chars)
- Article chars: 25127
- Extraction context chars: 12003
- Total seconds: 49.27

### Methodology Extraction

- `randomization_method`: Not reported
- `allocation_concealment_method`: Not reported
- `blinding_participants`: We conducted a single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial for 21 wk to test the effects of calcium supplementation and dairy intake on body fat and serum lipids in obese Puerto Ricans.
- `blinding_personnel`: Measurements were taken ... by the CRC-trained personnel, who were blinded to the study treatments.
- `blinding_outcome_assessors`: Measurements were taken while subjects wore light clothing, no shoes or accessories, by the CRC-trained personnel, who were blinded to the study treatments.
- `attrition_details`: Of the 46 subjects recruited, 10 did not qualify due to a calcium intake above 700 mg/d and 6 subjects retired before the initial visit. Therefore, 30 subjects were enrolled in the study. Five subjects dropped out from the study before the second visit; four females and one male. The reasons for not continuing in the study were as follows: one had medical reasons and four lost interest. Of the 25 subjects who completed the study, 20 were female and 5 were male. No further details on losses by...
- `study_design`: Single-center, randomized, placebo-controlled trial (described as "randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial").
- `additional_notes`: Interventions: three arms (high dairy group, high elemental calcium group [600 mg/d calcium carbonate], and control with placebo tablet). Subjects instructed to consume one tablet daily with lunch or dinner. Compliance monitored by monthly calendar, food records, FFQ, and 24-h recalls. Subjects advised to maintain usual physical activity and isocaloric intake; dairy products were provided monthly. No description of random sequence generation or allocation concealment procedures. No information...

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | High risk | Low risk / Not applicable | no | blinding_outcome_type_or_role_confusion |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk / Not applicable | yes |  |
| Incomplete outcome data: All outcomes | Unclear risk | Not applicable / Unclear risk | yes |  |

### Audit Details

#### Random sequence generation

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: The article states participants were "randomly assigned" but provides no description of the sequence generation process; per Cochrane criteria this insufficient information warrants an "Unclear risk" judgement.
- Model support: Comment: No information provided about how the random sequence was generated (randomization method not reported). Unable to determine whether a truly random method was used.
- Model support context: [{"source": "methodology", "quote": "randomization_method: \"Not reported\"", "relevance": "Explicitly states the sequence generation method was not reported."}, {"source": "article", "quote": "They were randomly assigned to one of the three treatments: high dairy group, high calcium group, and control.", "relevance": "States random assignment occurred but gives no details on the randomization procedure."}]
- GT support: Comment: mail from Dr Palacios: "The random sequence was computer generated"
- Evidence row: {}
- Source context preview: There are several strengths and limitations of the study. Strengths of this study include the following: design, calcium dose, and compliance measures. The design of the study, a randomized, double-blinded (single-blinded for the high dairy group), placebo-controlled trial with two calcium sources without energy-restricted diets or exercise intervention, allowed studying the effects of calcium alone on body composition and serum lipids under their usual free-living conditions. The total dose aimed in the study (four dairy products servings for the high dairy group and 1200 mg/d for the high calcium group) are similar to the US Dietary Guidelines and US DRI. In addition, these doses are...

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: The report states randomization occurred but provides no description of central allocation, sealed envelopes, or other concealment methods. Because concealment is not described, we cannot judge whether enrolment could have been influenced, so risk is Unclear.
- Model support: Comment: Allocation concealment not reported in the article. The methods state participants "were randomly assigned to one of the three treatments" but provide no details on how assignment was concealed, so it is unclear whether investigators/enrollers could foresee allocations.
- Model support context: [{"source": "article", "quote": "They were randomly assigned to one of the three treatments: high dairy group, high calcium group, and control.", "relevance": "Confirms random assignment but gives no information on concealment procedures."}, {"source": "methodology", "quote": "allocation_concealment_method: \"Not reported\"", "relevance": "Explicitly notes lack of reported allocation concealment details, leading to uncertainty about risk."}]
- GT support: Comment: mail from Dr Palacios: "The random sequence was computer generated and the allocation concealment was performed centrally"
- Evidence row: {}
- Source context preview: Forty-six sedentary obese male and female adults, aged 22–50 y, were recruited for the study through flyers, local newspaper, and radio advertisements in the San Juan area in Puerto Rico. Following preliminary screening by telephone, volunteers were invited to the CRC for an orientation meeting. A detailed description of the study was provided and written consent forms were obtained from each subject. Study eligibility criteria included being 21–50 y old, obese (defined by a body mass index (BMI), of 30 kg/m2 or more [23]), absence of chronic conditions, not taking calcium supplements or taking any medication regularly (including birth control pills, weight-reducing pills, insulin,...

#### Blinding of participants and personnel: All outcomes

- Prediction: High risk
- Ground truth: Low risk / Not applicable
- Match: False
- Model rationale: Because the high dairy intervention required providing visible foods and was only single-blinded, participants and likely some personnel knew allocation; outcomes (body composition, dietary intake) are susceptible to performance bias, so risk is high.
- Model support: Quote: "randomized, double-blind (single-blinded for the high dairy group), placebo-controlled trial" Comment: The report indicates the high dairy group was only single-blinded while other groups were double-blinded; participants in the dairy arm necessarily knew they were receiving dairy products (and personnel providing foods likely knew), so lack of participant/personnel blinding could have influenced outcomes like body weight/dietary intake. Probably not done for full blinding between interventions.
- Model support context: [{"source": "article", "quote": "randomized, double-blind (single-blinded for the high dairy group), placebo-controlled trial", "relevance": "States blinding was incomplete: dairy group single-blinded, implying participants/personnel could infer allocation."}, {"source": "methodology", "quote": "dairy products were provided monthly by the research team...high dairy group noted as single-blinded", "relevance": "Provision of foods and single-blind description suggest participants/personnel were not fully blinded, which can affect behavioral outcomes."}]
- GT support: Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric...
- Evidence row: {}
- Source context preview: There are several strengths and limitations of the study. Strengths of this study include the following: design, calcium dose, and compliance measures. The design of the study, a randomized, double-blinded (single-blinded for the high dairy group), placebo-controlled trial with two calcium sources without energy-restricted diets or exercise intervention, allowed studying the effects of calcium alone on body composition and serum lipids under their usual free-living conditions. The total dose aimed in the study (four dairy products servings for the high dairy group and 1200 mg/d for the high calcium group) are similar to the US Dietary Guidelines and US DRI. In addition, these doses are...

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk / Not applicable
- Match: True
- Model rationale: The study explicitly reports that CRC-trained personnel who performed measurements were blinded to treatment allocation, and outcomes (body composition, serum lipids) are measured by these assessors, so lack of assessor blinding is unlikely to have influenced outcome measurement.
- Model support: Quote: "Measurements were taken while subjects wore light clothing, no shoes or accessories, by the CRC-trained personnel, who were blinded to the study treatments." Comment: Blinded outcome assessment is explicitly stated for measurement personnel, so detection bias for measured outcomes is unlikely.
- Model support context: [{"source": "article", "quote": "Measurements were taken while subjects wore light clothing, no shoes or accessories, by the CRC-trained personnel, who were blinded to the study treatments.", "relevance": "Direct statement that outcome assessors (measurement staff) were blinded to treatment assignments."}, {"source": "methodology", "quote": "blinding_outcome_assessors: Measurements... by the CRC-trained personnel, who were blinded to the study treatments.", "relevance": "Confirms extracted methods indicate blinded outcome assessment, reducing detection bias risk."}]
- GT support: Blind outcome assessors | Blind outcome assessors | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study." | Blind outcome assessors | Blind outcome assessors | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr. Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study."
- Evidence row: {}
- Source context preview: There are several strengths and limitations of the study. Strengths of this study include the following: design, calcium dose, and compliance measures. The design of the study, a randomized, double-blinded (single-blinded for the high dairy group), placebo-controlled trial with two calcium sources without energy-restricted diets or exercise intervention, allowed studying the effects of calcium alone on body composition and serum lipids under their usual free-living conditions. The total dose aimed in the study (four dairy products servings for the high dairy group and 1200 mg/d for the high calcium group) are similar to the US Dietary Guidelines and US DRI. In addition, these doses are...

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: Not applicable / Unclear risk
- Match: True
- Model rationale: About 17% of randomized participants dropped out with reasons given, but the report lacks information on whether dropouts were balanced across groups or how missing data were analysed/handled; this insufficient reporting prevents judging the impact on outcome estimates, so the risk is unclear.
- Model support: Quote: "Five subjects dropped out from the study before the second visit; four females and one male. The reasons for not continuing in the study were as follows: one had medical reasons and four lost interest. ... No further details on losses by randomized group or handling of missing data reported." Comment: Missing outcome data exist (5/30, 17%) with reasons reported but the article does not report how these losses were distributed across randomized groups for all outcomes or how missing data were handled (no imputation methods described). Therefore risk of bias due to incomplete outcome data is unclear.
- Model support context: [{"source": "article", "quote": "Five subjects dropped out from the study before the second visit; four females and one male. The reasons ... one had medical reasons and four lost interest.", "relevance": "States number and reasons for attrition but not group allocation of dropouts."}, {"source": "methodology", "quote": "Of the 25 subjects who completed the study... No further details on losses by randomized group or handling of missing data reported.", "relevance": "Confirms lack of reporting on distribution of missing data and handling/imputation methods."}]
- GT support: 20 participants randomised and 17 assessed | 20 participants randomised and 17 assessed | Quote from publication: "There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Of the 25 subjects who completed the study, 20 were female and 5 were male. Within the ﬁve males, one was allocated to the high dairy group, two to the high calcium group, and two to the control group." Comment: attrition rates were 10% and 20% but relating to a small number of randomised participants (N = 10) in both groups | 20 participants randomised and 17 assessed | 20 participants randomised and 17 assessed | Quote from publication: "There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Of the 25 subjects who...
- Evidence row: {}
- Source context preview: Forty-six sedentary obese male and female adults, aged 22–50 y, were recruited for the study through flyers, local newspaper, and radio advertisements in the San Juan area in Puerto Rico. Following preliminary screening by telephone, volunteers were invited to the CRC for an orientation meeting. A detailed description of the study was provided and written consent forms were obtained from each subject. Study eligibility criteria included being 21–50 y old, obese (defined by a body mass index (BMI), of 30 kg/m2 or more [23]), absence of chronic conditions, not taking calcium supplements or taking any medication regularly (including birth control pills, weight-reducing pills, insulin,...


## 21775755 - Ziegler 2011

- Mode: hybrid
- Review context: none (0 chars)
- Article chars: 24371
- Extraction context chars: 12003
- Total seconds: 72.84

### Methodology Extraction

- `randomization_method`: "Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six."
- `allocation_concealment_method`: "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency."
- `blinding_participants`: "randomized, double-blind, placebo-controlled... using film-coated tablets containing 600 mg ALA ... or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance"
- `blinding_personnel`: Not reported
- `blinding_outcome_assessors`: "Experienced, trained, and certified (by P.J.D. and colleagues) physicians evaluated the NIS and NSC. Study physicians had participated in training sessions and actual examination of patients under observation using a formal certification process. The nerve conduction, quantitative sensory tests (QSTs), and autonomic tests were performed by trained and certified personnel (by P.A.L., W.J.L., P.J.D., and colleagues). All results were interactively evaluated by the Reading and Quality Assurance...
- `attrition_details`: Not reported
- `study_design`: "multicenter (36 centers ...), randomized, double-blind, placebo-controlled, two-arm, 1:1 allocation ratio, parallel-group clinical trial"
- `additional_notes`: "The random allocation was balanced using an undisclosed block size of six." "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency." Interim analysis: "At P < 0.005, the study would have been stopped. To ensure a global type 1 error of 5%, the error level for the final analysis was set to α2 = 0.0452 according to the Šidák (20) inequality."

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Low risk | Low risk | yes |  |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk | yes |  |
| Incomplete outcome data: All outcomes | Unclear risk | High risk | no | under-called_due_to_missing_or_underused_evidence |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The trial reports a randomization list generated by an independent Biostatistics Department and use of block balancing, which are explicit random methods satisfying the Low risk definition for sequence generation.
- Model support: Quote: "Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six." Comment: Probably done — a computer/generated randomization list with block randomization by an independent Biostatistics Department indicates a random sequence was used, meeting Low risk criteria.
- Model support context: [{"source": "article", "quote": "Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma.", "relevance": "Explicit statement that an independent biostatistics department generated the randomization list, showing a random component."}, {"source": "methodology", "quote": "\"The random allocation was balanced using an undisclosed block size of six.\"", "relevance": "Indicates use of block randomization to balance allocation, consistent with proper random sequence generation."}]
- GT support: Quote: "a randomization list was generated by the biostatistics department of the manufacturer of the study drug ..."
- Evidence row: {}
- Source context preview: Screened patients were assigned a unique five-digit number. Randomized patients were additionally assigned a four-digit randomization number at baseline. Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six. The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency. --- The Neurological Assessment of Thioctic Acid in Diabetic Neuropathy (NATHAN) 1 trial was a multicenter (36 centers in the U.S., Canada, and Europe [Supplementary Materials]), randomized,...

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: Although a randomization list was centrally generated, the report lacks sufficient detail that allocation was implemented in a way that recruiters/enrollers could not foresee assignments (no description of central allocation procedures or appropriately safeguarded sequentially numbered opaque envelopes). Therefore risk of concealment-related selection bias is unclear.
- Model support: Quote: "Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six." Comment: Random sequence was generated centrally, but there is no clear description that allocation was concealed from recruiters/enrollers (for example, central telephone/web allocation or sealed sequentially numbered opaque envelopes). The investigators and monitor had sealed envelopes for emergency decoding, but this does not confirm that allocation could not be foreseen prior to enrolment. Probably not done (insufficient detail).
- Model support context: [{"source": "article", "quote": "Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma.", "relevance": "Shows central generation of the random list but does not confirm concealment at point of enrolment."}, {"source": "methodology", "quote": "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency.", "relevance": "Describes sealed envelopes for emergency decoding only; does not state how allocation was kept concealed during enrolment."}]
- GT support: Quote: "a randomization list was generated by the biostatistics department of the manufacturer of the study drug, at distance of the centers the study took place"; "the random allocation was balanced using an undisclosed block size of six."
- Evidence row: {}
- Source context preview: Screened patients were assigned a unique five-digit number. Randomized patients were additionally assigned a four-digit randomization number at baseline. Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six. The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency. --- The Neurological Assessment of Thioctic Acid in Diabetic Neuropathy (NATHAN) 1 trial was a multicenter (36 centers in the U.S., Canada, and Europe [Supplementary Materials]), randomized,...

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The trial explicitly states it was double-blind with matching placebo tablets identical in appearance and emergency sealed envelopes for decoding, so participants and personnel were credibly masked and outcomes are unlikely to have been materially biased by lack of blinding.
- Model support: Quote: "randomized, double-blind, placebo-controlled... using film-coated tablets containing 600 mg ALA ... or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance" Comment: Blinding of participants and (presumably) site personnel was implemented with identical-appearing placebo tablets; emergency sealed decoding envelopes were provided. Probably done — unlikely that lack of blinding biased outcomes.
- Model support context: [{"source": "article", "quote": "randomized, double-blind, placebo-controlled... matching placebo tablets ... identical in appearance", "relevance": "Shows participants and treating staff were blinded using indistinguishable placebo."}, {"source": "methodology", "quote": "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency.", "relevance": "Indicates procedures to maintain blinding with emergency unblinding only."}]
- GT support: Quote: "... matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance." Comment: trial described as double-blind.
- Evidence row: {}
- Source context preview: The Neurological Assessment of Thioctic Acid in Diabetic Neuropathy (NATHAN) 1 trial was a multicenter (36 centers in the U.S., Canada, and Europe [Supplementary Materials]), randomized, double-blind, placebo-controlled, two-arm, 1:1 allocation ratio, parallel-group clinical trial using film-coated tablets containing 600 mg ALA (Thioctacid HR; MEDA Pharma, Bad Homburg, Germany) that were administered once daily or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance in diabetic patients with mild-to-moderate DSPN (18). The trial consisted of a 2-week screening phase, 6-week placebo run-in phase, 4-year double-blind phase, and 4-week...

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The study is explicitly double-blind with matching placebo and outcome measurements were conducted by trained/certified personnel with central reading/QA, making it unlikely that knowledge of allocation influenced outcome assessment; therefore detection bias is low.
- Model support: Quote: "Experienced, trained, and certified (by P.J.D. and colleagues) physicians evaluated the NIS and NSC. ... The nerve conduction, quantitative sensory tests (QSTs), and autonomic tests were performed by trained and certified personnel (by P.A.L., W.J.L., P.J.D., and colleagues). All results were interactively evaluated by the Reading and Quality Assurance Centers (at Mayo Clinic and Health Partners)." Comment: Outcome assessment was performed by trained/certified personnel and centrally reviewed, and the trial is described as double-blind with identical-appearing placebo, so assessors were very likely blinded. Probably done.
- Model support context: [{"source": "methodology", "quote": "\"Experienced, trained, and certified ... physicians evaluated the NIS and NSC.\"", "relevance": "Indicates specialized assessors performed outcomes, supporting standardized, blinded assessment."}, {"source": "article", "quote": "All results were interactively evaluated by the Reading and Quality Assurance Centers (at Mayo Clinic and Health Partners).", "relevance": "Central reading/QA reduces risk that local unblinded assessors could bias outcome measurement."}]
- GT support: Quote: "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency."
- Evidence row: {}
- Source context preview: The Neurological Assessment of Thioctic Acid in Diabetic Neuropathy (NATHAN) 1 trial was a multicenter (36 centers in the U.S., Canada, and Europe [Supplementary Materials]), randomized, double-blind, placebo-controlled, two-arm, 1:1 allocation ratio, parallel-group clinical trial using film-coated tablets containing 600 mg ALA (Thioctacid HR; MEDA Pharma, Bad Homburg, Germany) that were administered once daily or matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance in diabetic patients with mild-to-moderate DSPN (18). The trial consisted of a 2-week screening phase, 6-week placebo run-in phase, 4-year double-blind phase, and 4-week...

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: High risk
- Match: False
- Model rationale: There is insufficient reporting of the amount, reasons, balance, or methods used to handle missing outcome data in the provided materials; therefore we cannot determine whether attrition could bias the results.
- Model support: Comment: Attrition and handling of missing outcome data are not reported in the extracted methods or article excerpts. The paper planned for high dropout and an ITT analysis but provides no details on actual losses, reasons, balance across groups, or imputation methods, so risk of bias due to incomplete outcome data cannot be judged.
- Model support context: [{"source": "methodology", "quote": "attrition_details: Not reported", "relevance": "Directly indicates missing information about dropouts and handling of incomplete data."}, {"source": "article", "quote": "To account for a relatively high dropout rate expected in this long-term study, randomization of 250 patients per arm was proposed.", "relevance": "Shows authors anticipated dropout but no reported actual attrition or handling details in provided excerpts."}]
- GT support: More than 40% of participants discontinued intervention in both groups during the 4-year study. We do not know how many participants were lost before the outcomes at 2 years (our outcome of interest), and how many after the first 2 years. Most participants (454/460) were included in the ITT analysis, but the study authors did not report for how many they managed to measure the outcome, and for how many they used the last observation carried forward ("mean of weeks 191 and 192 or last available value after randomization"). Apparently, the proportion of dropouts and the causes of dropout were equally distributed among the 2 groups.
- Evidence row: {}
- Source context preview: We used a conservative approach to suggest that treatment with ALA may prevent worsening of DSPN but not necessarily cause improvement (16). A clinically meaningful treatment difference of 2.0 nds for the changes from baseline for NIS-LL+7 tests and statistical error probabilities α = 0.05 and β = 0.1 were assumed. Based on a two-sided t test, the following scenarios for SDs and sample size per group (n) were considered: SD 3.57, n = 68; SD 4, n = 86; SD 5, n = 133; SD 6, n = 191; SD 7, n = 211. To account for a relatively high dropout rate expected in this long-term study, randomization of 250 patients per arm was proposed. Analysis of the intention-to-treat population was primary for all...


## 22928960 - Houry 2012

- Mode: hybrid
- Review context: none (0 chars)
- Article chars: 20317
- Extraction context chars: 12006
- Total seconds: 70.52

### Methodology Extraction

- `randomization_method`: We used computer-generated randomization to assign new reviewers to either the intervention or control group.
- `allocation_concealment_method`: Not reported
- `blinding_participants`: All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors.
- `blinding_personnel`: Editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups.
- `blinding_outcome_assessors`: Outcome measures... were the mean review quality rating score for each reviewer, and the slope in change (improvement or deterioration) in editor-assigned reviewer quality ratings from their first review until the end date of the study. These were calculated from review scores recorded contemporaneously within our editorial management software.
- `attrition_details`: Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown).
- `study_design`: Randomized controlled trial
- `additional_notes`: Participants: consecutive individuals newly added to our reviewer ranks during the study period. There were no exclusion criteria. Mentors were senior journal reviewers who responded affirmatively to an email request for volunteers to mentor new reviewers. The content and amount of communication were left to the mentor and mentee. Data analysis used linear mixed effect models with Stata 10.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |
| Blinding of outcome assessment: All outcomes | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |
| Incomplete outcome data: All outcomes | Low risk | Low risk | yes |  |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The investigators explicitly state that a computer-generated randomization sequence was used, which meets the Cochrane criteria for low risk of bias in random sequence generation.
- Model support: Quote: "We used computer-generated randomization to assign new reviewers to either the intervention or control group." Comment: Probably done — a random component (computer-generated sequence) is explicitly reported, satisfying low-risk criteria for sequence generation.
- Model support context: [{"source": "article", "quote": "We used computer-generated randomization to assign new reviewers to either the intervention or control group.", "relevance": "Explicit description of a random component in sequence generation supports low risk."}, {"source": "methodology", "quote": "randomization_method: \"We used computer-generated randomization to assign new reviewers...\"", "relevance": "Extracted methods corroborate the article statement about computerized random sequence generation."}]
- GT support: Quote: "We used computer-generated randomization to assign new reviewers to either the intervention or control group."
- Evidence row: {}
- Source context preview: We used computer-generated randomization to assign new reviewers to either the intervention or control group. A senior editor emailed those in the intervention group and invited them to participate in a new mentoring program. Once agreed, they were provided detailed instructions on how to proceed. Those in the control group received no initial study-specific contacts and no intervention beyond standard journal practices outlined above. Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups. --- For those who might think this lack of efficacy is aberrant or unique to our...

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: Randomization method is described, but the specific procedure used to prevent foreknowledge of assignments (central allocation, sealed envelopes, or equivalent) is not reported; thus there is insufficient information to judge concealment.
- Model support: Quote: "We used computer-generated randomization to assign new reviewers to either the intervention or control group." Comment: Allocation concealment method not reported. There is some indication that editors invited reviewers "without knowledge of which new reviewers were assigned to the mentorship or control groups," which suggests concealment from editors, but no explicit description of a central randomization process or sealed envelopes. Therefore concealment is uncertain (Probably not clearly done).
- Model support context: [{"source": "article", "quote": "We used computer-generated randomization to assign new reviewers to either the intervention or control group.", "relevance": "Shows random sequence generation but does not describe concealment procedures."}, {"source": "article", "quote": "Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups.", "relevance": "Suggests editors were unaware of assignments, but does not document the allocation concealment mechanism."}]
- GT support: Computer-generated randomization and only a senior editor was aware of who was to receive the intervention.
- Evidence row: {}
- Source context preview: For those who might think this lack of efficacy is aberrant or unique to our journal environment, similar results have been reported in regards to teaching physicians critical appraisal skills in other settings. A Cochrane review cited found only one randomized trial on teaching critical appraisal skills rigorous enough and stated that conclusions about the effects of teaching critical appraisal are debatable [18]. Another educational trial which randomized practitioners to half-day critical appraisal skills training workshop or wait list control found that those who took their course had a greater overall knowledge score, but no differences in overall attitude towards evidence, perceived...

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: Editors invited reviewers without knowledge of allocation and the peer-review system is blinded; outcomes were objective editor quality ratings within software and unlikely to be influenced by lack of participant/personnel blinding, so risk of performance bias is low.
- Model support: Quote: "All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors." Comment: Participants (reviewers) and editorial staff who selected reviewers were unaware of group allocation when inviting reviewers; allocation was concealed from editors in their standard invitations. Outcomes (editor-assigned quality scores recorded in software) were unlikely to be materially biased by knowledge of allocation. Probably done.
- Model support context: [{"source": "article", "quote": "All peer review at our journal is blinded; however after a decision is made... we provide the reviewer blinded copies of all the comments...", "relevance": "Shows peer-review process is blinded and reviewers receive only blinded materials, reducing performance bias."}, {"source": "methodology", "quote": "Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups.", "relevance": "Indicates editors (personnel) were unaware of allocation when inviting reviewers, supporting effective blinding of personnel."}]
- GT support: Quote: "Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups." Comment: personnel were blinded but unclear if participants were blinded.
- Evidence row: {}
- Source context preview: For those who might think this lack of efficacy is aberrant or unique to our journal environment, similar results have been reported in regards to teaching physicians critical appraisal skills in other settings. A Cochrane review cited found only one randomized trial on teaching critical appraisal skills rigorous enough and stated that conclusions about the effects of teaching critical appraisal are debatable [18]. Another educational trial which randomized practitioners to half-day critical appraisal skills training workshop or wait list control found that those who took their course had a greater overall knowledge score, but no differences in overall attitude towards evidence, perceived...

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: Editor-assigned quality ratings were recorded contemporaneously within routine, blinded peer-review processes; there is no indication assessors knew allocation and outcomes are unlikely to be influenced by lack of blinding, supporting Low risk.
- Model support: Quote: "All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors." Comment: Probably done — outcome assessment (editor-assigned reviewer quality ratings recorded contemporaneously in editorial management software) was based on routine blinded peer-review processes and scores recorded independently of intervention, making it unlikely that lack of assessor blinding biased measurement.
- Model support context: [{"source": "article", "quote": "All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers...", "relevance": "Indicates reviewers were blinded in standard process, reducing risk that knowledge influenced scores."}, {"source": "methodology", "quote": "Outcome measures... were the mean review quality rating score for each reviewer... calculated from review scores recorded contemporaneously within our editorial management software.", "relevance": "Outcomes were objective ratings recorded routinely and not derived from unblinded assessors aware of allocation."}]
- GT support: Quote: "All reviews at Annals are routinely rated by editors for quality on a previously reported 5-point scale that has demonstrated moderate reliability and is comparable to the scale validated by van Rooyen." Comment: unclear if the editors were aware of allocation when assessing the reviews.
- Evidence row: {}
- Source context preview: Our main outcome measures were the mean review quality rating score for each reviewer, and the slope in change (improvement or deterioration) in editor-assigned reviewer quality ratings from their first review until the end date of the study. These were calculated from review scores recorded contemporaneously within our editorial management software. --- We hypothesized that perhaps these failures were due to an insufficiently focused and detailed mentoring process, which has been deemed necessary in previous studies of teaching complex writing skills [16]. We therefore attempted to develop a more individualized and detailed approach that would still not represent too great a burden on the...

#### Incomplete outcome data: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: There were a small number (four) of randomized participants who did not receive intervention, but the authors conducted an ITT analysis and found essentially identical results to per-protocol, and follow-up appears balanced; therefore missing outcome data are unlikely to have materially biased the effect estimates.
- Model support: Quote: "Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown)." Comment: Although four randomized participants in the intervention arm did not receive the intervention, the authors performed an intention-to-treat analysis and report it produced essentially identical results to the per-protocol analysis, suggesting missing data are unlikely to have biased the outcomes. Probably done.
- Model support context: [{"source": "article", "quote": "Four subjects randomized to the mentorship group never made contact of any kind with their mentors...we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown).", "relevance": "Direct statement about missing participants and that ITT analysis was performed with similar results, indicating limited risk from attrition."}, {"source": "methodology", "quote": "37 reviewers returned the survey of their experience (17 controls and 20 mentees)", "relevance": "Shows follow-up/survey response rates appear balanced between groups, supporting that missing data were not substantially differential."}]
- GT support: Quote: "per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown)." Comment: 4 subjects in the intervention group did not receive the intervention and were excluded from the analysis. The researchers state that an ITT analysis "yielded essentially identical results" but the analyses are not included in the paper.
- Evidence row: {}
- Source context preview: Participant flow is shown in Figure 1. Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown). 37 reviewers returned the survey of their experience (17 controls and 20 mentees); of these all had had at least one category of prior training (see Table 1). --- We hypothesized that perhaps these failures were due to an insufficiently focused and detailed mentoring process, which has been...


## 23148458 - Sheridan 2012

- Mode: hybrid
- Review context: none (0 chars)
- Article chars: 34179
- Extraction context chars: 12003
- Total seconds: 49.18

### Methodology Extraction

- `randomization_method`: "Randomization used computer-generated random numbers that were sealed in opaque envelopes."
- `allocation_concealment_method`: "Randomization used computer-generated random numbers that were sealed in opaque envelopes."
- `blinding_participants`: Not reported
- `blinding_personnel`: Not reported
- `blinding_outcome_assessors`: "Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)"
- `attrition_details`: Not reported
- `study_design`: "randomized controlled trials" (two trials combined); individual randomization within practices (participants randomized within practices)
- `additional_notes`: Intervention delivered prior to regularly scheduled appointments in a private room; control was an attention control video (highway safety). Physicians were invited to attend a 1-hour educational session and provided informed consent; physicians who participated were notified about patients' participation but not group assignment. Data from two parallel trials (prostate only and men's health) were combined for analysis.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Low risk | Low risk | yes |  |
| Blinding of participants and personnel: All outcomes | High risk | Low risk | no | blinding_outcome_type_or_role_confusion |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk | yes |  |
| Incomplete outcome data: All outcomes | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The trial report explicitly states that computer-generated random numbers were used to allocate participants, which meets the Cochrane criteria for a low risk random sequence generation method.
- Model support: Quote: "Randomization used computer-generated random numbers that were sealed in opaque envelopes." Comment: Sequence generation involved a computer random number generator, a clearly random method. Probably done as described, supporting low risk of bias for random sequence generation.
- Model support context: [{"source": "article", "quote": "Randomization used computer-generated random numbers that were sealed in opaque envelopes.", "relevance": "Describes a random component (computer-generated numbers) used to generate the allocation sequence."}, {"source": "methodology", "quote": "\"Randomization used computer-generated random numbers that were sealed in opaque envelopes.\"", "relevance": "Confirms extracted methods indicating use of a computer random number generator for sequence generation."}]
- GT support: Randomisation used computer‐generated random numbers that were sealed in opaque envelopes.
- Evidence row: {}
- Source context preview: Between March 2005 and April 2006, we conducted two randomized controlled trials of the same prostate cancer screening intervention, alone or with additional information on two more clearly beneficial men’s health screening services (cardiovascular disease screening and colon cancer screening). We conducted each trial in a convenience sample from two practices (one academic and one community practice) within a single city (Chapel Hill, NC for the prostate only intervention and Greensboro, NC for the men’s health intervention). In both trials, we used the same educational video on highway safety (“Reducing Your Risk in a Crash” available at http://www.iihs.org/videos/default.html) as an...

#### Allocation concealment

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The study reports use of computer-generated random numbers placed in sealed opaque envelopes, a method that prevents foreknowledge of upcoming assignments by those enrolling participants, meeting the Cochrane criteria for low risk of allocation concealment bias.
- Model support: Quote: "Randomization used computer-generated random numbers that were sealed in opaque envelopes." Comment: Probably done — allocation was concealed using sealed opaque envelopes, which prevents recruiters/enrollers from foreseeing assignments.
- Model support context: [{"source": "article", "quote": "Randomization used computer-generated random numbers that were sealed in opaque envelopes.", "relevance": "Describes the method used to conceal allocation, matching Cochrane criteria for adequate concealment."}, {"source": "methodology", "quote": "\"Randomization used computer-generated random numbers that were sealed in opaque envelopes.\"", "relevance": "Confirms allocation concealment approach in extracted methods supporting low risk."}]
- GT support: Randomisation used computer‐generated random numbers that were sealed in opaque envelopes.
- Evidence row: {}
- Source context preview: The patient intervention and accompanying surveys were delivered to participants prior to regularly scheduled medical appointments in a private room in each practice. After providing informed consent and completing a baseline survey, eligible men were randomized within practices to receive one of the SDM interventions or a highway safety control video. Randomization used computer-generated random numbers that were sealed in opaque envelopes. Men in the intervention groups watched one of our informational videos and then were guided through a coaching session by a trained research assistant. At the end of the coaching session, men were given a summary sheet of their opinions on prostate...

#### Blinding of participants and personnel: All outcomes

- Prediction: High risk
- Ground truth: Low risk
- Match: False
- Model rationale: The interventions differed markedly (coaching plus summary vs control video only), making participant and personnel blinding implausible; primary outcomes were participant-reported knowledge and participation, which are likely biased by knowledge of group assignment, meeting criteria for high risk of performance bias.
- Model support: Quote: "Men in the intervention groups watched one of our informational videos and then were guided through a coaching session by a trained research assistant... Men in the highway safety group viewed the highway safety video, but received no accompanying coaching session." Comment: Participants and personnel were almost certainly aware of group assignment (intervention involved coaching and summary sheet vs control only a video); outcomes were patient-reported (knowledge, participation) and thus likely influenced by lack of blinding. Probably not done.
- Model support context: [{"source": "article", "quote": "After providing informed consent... men were randomized... Men in the intervention groups watched one of our informational videos and then were guided through a coaching session... Men in the highway safety group viewed the highway safety...", "relevance": "Shows clear differences in participant experience that would reveal allocation and could influence self-reported outcomes."}, {"source": "methodology", "quote": "blinding_participants: Not reported; blinding_personnel: Not reported", "relevance": "No indication that participant or personnel blinding was implemented or possible given the intervention delivery."}]
- GT support: "Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)." Although described as single‐masked in the study registration, due to the attention control intervention in the control groups, both participants and staff could be considered blinded.
- Evidence row: {}
- Source context preview: Between March 2005 and April 2006, we conducted two randomized controlled trials of the same prostate cancer screening intervention, alone or with additional information on two more clearly beneficial men’s health screening services (cardiovascular disease screening and colon cancer screening). We conducted each trial in a convenience sample from two practices (one academic and one community practice) within a single city (Chapel Hill, NC for the prostate only intervention and Greensboro, NC for the men’s health intervention). In both trials, we used the same educational video on highway safety (“Reducing Your Risk in a Crash” available at http://www.iihs.org/videos/default.html) as an...

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: Physicians who would influence or record key outcomes were notified only of participation and not group assignment, and outcome measures included patient surveys and clinical decisions made during visits; therefore lack of assessor knowledge makes detection bias unlikely.
- Model support: Quote: "Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)" Comment: Outcome assessment (patient surveys and subsequent physician encounters/recorded screening decisions) was likely performed without assessors knowing allocation; physicians were unaware of group assignment, reducing detection bias. Probably done.
- Model support context: [{"source": "methodology", "quote": "\"Men then proceeded to their visit with their physician (who was notified only about patients’ participation, but not group assignment)\"", "relevance": "Shows physicians (outcome-influencing clinicians) were not told group assignment, reducing assessor knowledge."}, {"source": "article", "quote": "After providing informed consent... men were randomized... Men in the intervention groups watched one of our informational videos and then were guided through a coaching session...", "relevance": "Describes intervention delivery and timing relative to outcome assessment (before visit), supporting that assessors were likely blind to allocation."}]
- GT support: Self‐reported outcome measures, therefore, low risk considering masking of participants.
- Evidence row: {}
- Source context preview: Between March 2005 and April 2006, we conducted two randomized controlled trials of the same prostate cancer screening intervention, alone or with additional information on two more clearly beneficial men’s health screening services (cardiovascular disease screening and colon cancer screening). We conducted each trial in a convenience sample from two practices (one academic and one community practice) within a single city (Chapel Hill, NC for the prostate only intervention and Greensboro, NC for the men’s health intervention). In both trials, we used the same educational video on highway safety (“Reducing Your Risk in a Crash” available at http://www.iihs.org/videos/default.html) as an...

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: Insufficient reporting: the article excerpts and extracted methods do not state numbers or reasons for missing outcome data or how they were handled, preventing assessment of potential bias from incomplete outcome data.
- Model support: Comment: The report does not provide information on numbers or reasons for loss to follow-up or missing outcome data in the main text excerpts provided, so I cannot determine whether missing data were balanced, related to outcomes, or appropriately handled.
- Model support context: [{"source": "article", "quote": "After completion of these interventions, all men completed a 2nd questionnaire to assess immediate changes in their knowledge and attitudes about prostate cancer screening. Men then proceeded to their visit with their physician (who was...", "relevance": "Describes flow through intervention and assessment but gives no attrition or missing-data figures or reasons."}, {"source": "methodology", "quote": "attrition_details: \"Not reported\"", "relevance": "Explicitly indicates attrition/missing outcome data were not reported in the extracted methods."}]
- GT support: SeeFigure 1for reporting on missing data (only 2 participants in intervention group due to false inclusion)
- Evidence row: {}
- Source context preview: Between March 2005 and April 2006, we conducted two randomized controlled trials of the same prostate cancer screening intervention, alone or with additional information on two more clearly beneficial men’s health screening services (cardiovascular disease screening and colon cancer screening). We conducted each trial in a convenience sample from two practices (one academic and one community practice) within a single city (Chapel Hill, NC for the prostate only intervention and Greensboro, NC for the men’s health intervention). In both trials, we used the same educational video on highway safety (“Reducing Your Risk in a Crash” available at http://www.iihs.org/videos/default.html) as an...

## Workflow Evolution Notes

- Inspect mismatches where prediction is `Unclear risk` but GT is `Low risk`: these usually mean retrieval or Stage 1 extraction missed a concrete methodological phrase.
- Inspect mismatches where prediction is `Low risk` or `High risk` but GT is `Unclear risk`: these usually mean the prompt is allowing too much inference from generic trial language.
- For blinding mismatches, add outcome-type cues to the prompt: self-report outcomes, objective outcomes, assessor-administered outcomes, and whether lack of blinding can materially affect the outcome.
- For allocation concealment mismatches, require the model to distinguish sequence generation from concealment before assignment.